

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.85080985 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.32424298 |
| 3 | response to peptidoglycan (GO:0032494) | 4.12810926 |
| 4 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.10720547 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.05971786 |
| 6 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.05971786 |
| 7 | positive thymic T cell selection (GO:0045059) | 3.92720001 |
| 8 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.85108547 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 3.66996136 |
| 10 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.65441514 |
| 11 | detection of other organism (GO:0098543) | 3.62777490 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.61642577 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 3.55933283 |
| 14 | negative T cell selection (GO:0043383) | 3.50826165 |
| 15 | negative thymic T cell selection (GO:0045060) | 3.50036810 |
| 16 | leukocyte aggregation (GO:0070486) | 3.46461123 |
| 17 | negative regulation of T cell mediated immunity (GO:0002710) | 3.46197071 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.45638500 |
| 19 | negative regulation of cell killing (GO:0031342) | 3.45638500 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 3.39593094 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.37706104 |
| 22 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.36533009 |
| 23 | detection of bacterium (GO:0016045) | 3.36030358 |
| 24 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.28709053 |
| 25 | neutrophil activation (GO:0042119) | 3.28034836 |
| 26 | thymic T cell selection (GO:0045061) | 3.27018860 |
| 27 | detection of external biotic stimulus (GO:0098581) | 3.24245609 |
| 28 | positive regulation of granulocyte differentiation (GO:0030854) | 3.17821740 |
| 29 | interferon-gamma production (GO:0032609) | 3.15757000 |
| 30 | hepatocyte apoptotic process (GO:0097284) | 3.14501300 |
| 31 | neutrophil mediated immunity (GO:0002446) | 3.14261425 |
| 32 | cell adhesion mediated by integrin (GO:0033627) | 3.13827753 |
| 33 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.12720444 |
| 34 | response to host immune response (GO:0052572) | 3.12720444 |
| 35 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.12015224 |
| 36 | response to host (GO:0075136) | 3.12015224 |
| 37 | response to host defenses (GO:0052200) | 3.12015224 |
| 38 | microglial cell activation (GO:0001774) | 3.11952479 |
| 39 | positive regulation of mast cell activation (GO:0033005) | 3.11161325 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.10681788 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.07603575 |
| 42 | positive T cell selection (GO:0043368) | 3.04253552 |
| 43 | regulation of mast cell degranulation (GO:0043304) | 3.00914271 |
| 44 | macrophage activation (GO:0042116) | 2.99259226 |
| 45 | granulocyte activation (GO:0036230) | 2.96984127 |
| 46 | regulation of mast cell activation (GO:0033003) | 2.96351786 |
| 47 | regulation of tolerance induction (GO:0002643) | 2.95851002 |
| 48 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.93336543 |
| 49 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.91932145 |
| 50 | detection of biotic stimulus (GO:0009595) | 2.89910833 |
| 51 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.89080023 |
| 52 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.89080023 |
| 53 | NIK/NF-kappaB signaling (GO:0038061) | 2.88944244 |
| 54 | regulation of regulatory T cell differentiation (GO:0045589) | 2.88889767 |
| 55 | defense response to protozoan (GO:0042832) | 2.87328881 |
| 56 | T cell selection (GO:0045058) | 2.87293761 |
| 57 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.86806426 |
| 58 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.86138176 |
| 59 | response to interleukin-15 (GO:0070672) | 2.86103718 |
| 60 | hypotonic response (GO:0006971) | 2.85853656 |
| 61 | positive regulation of tolerance induction (GO:0002645) | 2.85851867 |
| 62 | leukocyte cell-cell adhesion (GO:0007159) | 2.84804962 |
| 63 | B cell mediated immunity (GO:0019724) | 2.84645809 |
| 64 | response to muramyl dipeptide (GO:0032495) | 2.83921633 |
| 65 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.82643513 |
| 66 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.79411944 |
| 67 | cellular extravasation (GO:0045123) | 2.76257948 |
| 68 | response to type I interferon (GO:0034340) | 2.75929213 |
| 69 | actin nucleation (GO:0045010) | 2.73725883 |
| 70 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.73204880 |
| 71 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.72707525 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.72339895 |
| 73 | type I interferon signaling pathway (GO:0060337) | 2.70596476 |
| 74 | cellular response to type I interferon (GO:0071357) | 2.70596476 |
| 75 | activated T cell proliferation (GO:0050798) | 2.70151117 |
| 76 | regulation of T cell tolerance induction (GO:0002664) | 2.67665661 |
| 77 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.67414354 |
| 78 | positive regulation of isotype switching (GO:0045830) | 2.67066118 |
| 79 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.66771311 |
| 80 | positive regulation of macrophage differentiation (GO:0045651) | 2.65534939 |
| 81 | positive regulation of interferon-alpha production (GO:0032727) | 2.64880261 |
| 82 | positive regulation by symbiont of host defense response (GO:0052509) | 2.64803726 |
| 83 | modulation by symbiont of host defense response (GO:0052031) | 2.64803726 |
| 84 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.64803726 |
| 85 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.64803726 |
| 86 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.64803726 |
| 87 | modulation by symbiont of host immune response (GO:0052553) | 2.64803726 |
| 88 | glomerular visceral epithelial cell development (GO:0072015) | 2.64761638 |
| 89 | mast cell activation (GO:0045576) | 2.64760512 |
| 90 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.64300305 |
| 91 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.64015358 |
| 92 | positive regulation of mast cell degranulation (GO:0043306) | 2.64015358 |
| 93 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.63858544 |
| 94 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.63600083 |
| 95 | T cell migration (GO:0072678) | 2.63127435 |
| 96 | regulation of B cell differentiation (GO:0045577) | 2.62557116 |
| 97 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.55403810 |
| 98 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.54710681 |
| 99 | regulation of necroptotic process (GO:0060544) | 2.54117498 |
| 100 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.53611053 |
| 101 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.53096474 |
| 102 | regulation of interferon-alpha production (GO:0032647) | 2.52668886 |
| 103 | immunoglobulin mediated immune response (GO:0016064) | 2.52065529 |
| 104 | growth hormone receptor signaling pathway (GO:0060396) | 2.50287657 |
| 105 | T cell costimulation (GO:0031295) | 2.49890384 |
| 106 | regulation of response to interferon-gamma (GO:0060330) | 2.49368486 |
| 107 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.48936888 |
| 108 | heterotypic cell-cell adhesion (GO:0034113) | 2.48126230 |
| 109 | neutrophil activation involved in immune response (GO:0002283) | 2.48030628 |
| 110 | positive regulation of lamellipodium assembly (GO:0010592) | 2.47774482 |
| 111 | angiogenesis involved in wound healing (GO:0060055) | 2.47365662 |
| 112 | B cell receptor signaling pathway (GO:0050853) | 2.46668692 |
| 113 | tyrosine phosphorylation of STAT protein (GO:0007260) | 2.46299663 |
| 114 | myeloid dendritic cell activation (GO:0001773) | 2.45769807 |
| 115 | tolerance induction (GO:0002507) | 2.45026428 |
| 116 | negative regulation of interleukin-12 production (GO:0032695) | 2.44825666 |
| 117 | positive regulation of B cell differentiation (GO:0045579) | 2.44465829 |
| 118 | establishment of endothelial barrier (GO:0061028) | 2.44373501 |
| 119 | lymphocyte costimulation (GO:0031294) | 2.43663245 |
| 120 | cellular response to interleukin-15 (GO:0071350) | 2.43496101 |
| 121 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.41045493 |
| 122 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.40691528 |
| 123 | pinocytosis (GO:0006907) | 2.40424452 |
| 124 | myeloid dendritic cell differentiation (GO:0043011) | 2.39576856 |
| 125 | wound healing, spreading of cells (GO:0044319) | 2.39113458 |
| 126 | response to protozoan (GO:0001562) | 2.38955356 |
| 127 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.38862268 |
| 128 | substrate-dependent cell migration (GO:0006929) | 2.37913116 |
| 129 | negative regulation of phagocytosis (GO:0050765) | 2.37388357 |
| 130 | wound healing, spreading of epidermal cells (GO:0035313) | 2.37189863 |
| 131 | fibroblast migration (GO:0010761) | 2.36106215 |
| 132 | germinal center formation (GO:0002467) | 2.35160367 |
| 133 | positive regulation of lamellipodium organization (GO:1902745) | 2.35134044 |
| 134 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.34813354 |
| 135 | positive regulation of humoral immune response (GO:0002922) | 2.34089119 |
| 136 | response to laminar fluid shear stress (GO:0034616) | 2.31895162 |
| 137 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.30842446 |
| 138 | positive regulation of interleukin-2 production (GO:0032743) | 2.28800454 |
| 139 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.28042349 |
| 140 | positive regulation of B cell mediated immunity (GO:0002714) | 2.28042349 |
| 141 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.27711944 |
| 142 | natural killer cell activation (GO:0030101) | 2.27027044 |
| 143 | T cell apoptotic process (GO:0070231) | 2.26761510 |
| 144 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.26483758 |
| 145 | natural killer cell differentiation (GO:0001779) | 2.26040588 |
| 146 | membrane raft organization (GO:0031579) | 2.24459372 |
| 147 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.22942036 |
| 148 | skin morphogenesis (GO:0043589) | 2.22925754 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.98277208 |
| 2 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.54776621 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.08322222 |
| 4 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.99577049 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.81850573 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.78048828 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.03670370 |
| 8 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.81807770 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.80013190 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.78424889 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.69097977 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.65563406 |
| 13 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.57070164 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52355921 |
| 15 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.48747308 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.44545878 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.39004352 |
| 18 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.36761739 |
| 19 | * MYC_22102868_ChIP-Seq_BL_Human | 2.35588662 |
| 20 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.31446844 |
| 21 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.26311333 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.21181911 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.15305771 |
| 24 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.15139718 |
| 25 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.14011658 |
| 26 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.09602268 |
| 27 | * MAF_26560356_Chip-Seq_TH1_Human | 2.08429085 |
| 28 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.07879376 |
| 29 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.97331939 |
| 30 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92206600 |
| 31 | * MYB_26560356_Chip-Seq_TH1_Human | 1.91985338 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.87123738 |
| 33 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.86413200 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.86148029 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.84593625 |
| 36 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.83100749 |
| 37 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.82570388 |
| 38 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.74669090 |
| 39 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.74578177 |
| 40 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.73067056 |
| 41 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.67599590 |
| 42 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.64322784 |
| 43 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63193141 |
| 44 | SPI1_23127762_ChIP-Seq_K562_Human | 1.61166325 |
| 45 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.60043464 |
| 46 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.59267888 |
| 47 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.59267888 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.52442385 |
| 49 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.50335476 |
| 50 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47221745 |
| 51 | GATA1_22025678_ChIP-Seq_K562_Human | 1.46587838 |
| 52 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.45274033 |
| 53 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.43093291 |
| 54 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.42150089 |
| 55 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.40908860 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40538781 |
| 57 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39620494 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.39454020 |
| 59 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.37964393 |
| 60 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.37469015 |
| 61 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.36811931 |
| 62 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.36720620 |
| 63 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.36527153 |
| 64 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.35657924 |
| 65 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33215447 |
| 66 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.32457953 |
| 67 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32268354 |
| 68 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30794345 |
| 69 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.29785076 |
| 70 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.29360161 |
| 71 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.29063150 |
| 72 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.27577317 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25177184 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24901883 |
| 75 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23888930 |
| 76 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.22337312 |
| 77 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.19313531 |
| 78 | CJUN_26792858_Chip-Seq_BT549_Human | 1.16960255 |
| 79 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15615097 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.14901323 |
| 81 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14239346 |
| 82 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14103136 |
| 83 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13953520 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13475497 |
| 85 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.13441854 |
| 86 | * JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.11585032 |
| 87 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10480524 |
| 88 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10377058 |
| 89 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09573088 |
| 90 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.08545621 |
| 91 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.07588644 |
| 92 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.06970435 |
| 93 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.06802731 |
| 94 | GATA2_19941826_ChIP-Seq_K562_Human | 1.06251769 |
| 95 | MAF_26560356_Chip-Seq_TH2_Human | 1.05720583 |
| 96 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.04129688 |
| 97 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03871851 |
| 98 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.00733222 |
| 99 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.98526586 |
| 100 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96772533 |
| 101 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.96352704 |
| 102 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96265395 |
| 103 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.95855431 |
| 104 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95311606 |
| 105 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.95265639 |
| 106 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95077010 |
| 107 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94968431 |
| 108 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94968431 |
| 109 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.94948504 |
| 110 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94027499 |
| 111 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.91837948 |
| 112 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91765650 |
| 113 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91564504 |
| 114 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.91258757 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91233235 |
| 116 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.90551455 |
| 117 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90298489 |
| 118 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.89779183 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89029361 |
| 120 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.88843919 |
| 121 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.88127907 |
| 122 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87705179 |
| 123 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.84261824 |
| 124 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82611661 |
| 125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77530660 |
| 126 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.77199991 |
| 127 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.77185778 |
| 128 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75185049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 2.68141603 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.67230061 |
| 3 | MP0003436_decreased_susceptibility_to | 2.54547512 |
| 4 | MP0003303_peritoneal_inflammation | 2.37721813 |
| 5 | MP0000685_abnormal_immune_system | 2.35922339 |
| 6 | MP0003300_gastrointestinal_ulcer | 2.29510654 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.28892917 |
| 8 | MP0003566_abnormal_cell_adhesion | 2.26880790 |
| 9 | MP0005671_abnormal_response_to | 2.14559059 |
| 10 | MP0009785_altered_susceptibility_to | 2.11999295 |
| 11 | MP0003763_abnormal_thymus_physiology | 2.09842021 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.00206156 |
| 13 | MP0001800_abnormal_humoral_immune | 1.99004900 |
| 14 | MP0002396_abnormal_hematopoietic_system | 1.98743914 |
| 15 | MP0004808_abnormal_hematopoietic_stem | 1.96301160 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 1.95189202 |
| 17 | MP0002452_abnormal_antigen_presenting | 1.93280145 |
| 18 | MP0002166_altered_tumor_susceptibility | 1.93173879 |
| 19 | MP0001790_abnormal_immune_system | 1.89538172 |
| 20 | MP0005387_immune_system_phenotype | 1.89538172 |
| 21 | MP0002006_tumorigenesis | 1.83687929 |
| 22 | MP0003279_aneurysm | 1.83565621 |
| 23 | MP0002419_abnormal_innate_immunity | 1.81800092 |
| 24 | MP0003091_abnormal_cell_migration | 1.77936469 |
| 25 | MP0002405_respiratory_system_inflammati | 1.77610111 |
| 26 | MP0002420_abnormal_adaptive_immunity | 1.76880280 |
| 27 | MP0001819_abnormal_immune_cell | 1.76204707 |
| 28 | MP0002723_abnormal_immune_serum | 1.75555449 |
| 29 | MP0005023_abnormal_wound_healing | 1.74396545 |
| 30 | MP0005025_abnormal_response_to | 1.71627087 |
| 31 | MP0004947_skin_inflammation | 1.69765066 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.68137887 |
| 33 | MP0001873_stomach_inflammation | 1.67922786 |
| 34 | MP0002933_joint_inflammation | 1.64934284 |
| 35 | MP0002877_abnormal_melanocyte_morpholog | 1.63493209 |
| 36 | MP0002148_abnormal_hypersensitivity_rea | 1.61723900 |
| 37 | MP0002398_abnormal_bone_marrow | 1.60103944 |
| 38 | MP0000858_altered_metastatic_potential | 1.58459005 |
| 39 | MP0005464_abnormal_platelet_physiology | 1.57969347 |
| 40 | MP0003828_pulmonary_edema | 1.56890087 |
| 41 | MP0010155_abnormal_intestine_physiology | 1.56826219 |
| 42 | MP0009278_abnormal_bone_marrow | 1.52146893 |
| 43 | MP0000569_abnormal_digit_pigmentation | 1.52085397 |
| 44 | MP0003448_altered_tumor_morphology | 1.52013676 |
| 45 | MP0008438_abnormal_cutaneous_collagen | 1.50099994 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.49122812 |
| 47 | MP0004381_abnormal_hair_follicle | 1.48223301 |
| 48 | MP0001853_heart_inflammation | 1.47773105 |
| 49 | MP0005076_abnormal_cell_differentiation | 1.45881068 |
| 50 | MP0002138_abnormal_hepatobiliary_system | 1.44682518 |
| 51 | MP0009333_abnormal_splenocyte_physiolog | 1.43846823 |
| 52 | MP0005397_hematopoietic_system_phenotyp | 1.42788838 |
| 53 | MP0001545_abnormal_hematopoietic_system | 1.42788838 |
| 54 | MP0000716_abnormal_immune_system | 1.42708639 |
| 55 | MP0005451_abnormal_body_composition | 1.41852198 |
| 56 | MP0004084_abnormal_cardiac_muscle | 1.41676829 |
| 57 | MP0003724_increased_susceptibility_to | 1.41609692 |
| 58 | MP0001958_emphysema | 1.39432662 |
| 59 | MP0004883_abnormal_blood_vessel | 1.37439377 |
| 60 | MP0006054_spinal_hemorrhage | 1.36320300 |
| 61 | MP0003172_abnormal_lysosome_physiology | 1.36042320 |
| 62 | MP0010368_abnormal_lymphatic_system | 1.35247877 |
| 63 | MP0002132_abnormal_respiratory_system | 1.34203036 |
| 64 | MP0006082_CNS_inflammation | 1.33351836 |
| 65 | MP0002722_abnormal_immune_system | 1.31546324 |
| 66 | MP0000689_abnormal_spleen_morphology | 1.31171566 |
| 67 | MP0003646_muscle_fatigue | 1.30000448 |
| 68 | MP0000343_altered_response_to | 1.28922848 |
| 69 | MP0001845_abnormal_inflammatory_respons | 1.28568986 |
| 70 | MP0005164_abnormal_response_to | 1.28544779 |
| 71 | MP0000733_abnormal_muscle_development | 1.27259653 |
| 72 | MP0010234_abnormal_vibrissa_follicle | 1.26764747 |
| 73 | MP0000465_gastrointestinal_hemorrhage | 1.25104061 |
| 74 | MP0003045_fibrosis | 1.21243572 |
| 75 | MP0002429_abnormal_blood_cell | 1.21169238 |
| 76 | MP0000767_abnormal_smooth_muscle | 1.18793617 |
| 77 | MP0009764_decreased_sensitivity_to | 1.17517351 |
| 78 | MP0000703_abnormal_thymus_morphology | 1.14549972 |
| 79 | MP0003183_abnormal_peptide_metabolism | 1.10688804 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 1.10600644 |
| 81 | MP0000490_abnormal_crypts_of | 1.08074593 |
| 82 | MP0005075_abnormal_melanosome_morpholog | 1.06786332 |
| 83 | MP0002998_abnormal_bone_remodeling | 1.05235935 |
| 84 | MP0010307_abnormal_tumor_latency | 1.04087623 |
| 85 | MP0008260_abnormal_autophagy | 1.03963939 |
| 86 | MP0000750_abnormal_muscle_regeneration | 1.03546076 |
| 87 | MP0001851_eye_inflammation | 1.02020205 |
| 88 | MP0004185_abnormal_adipocyte_glucose | 0.99666934 |
| 89 | MP0003656_abnormal_erythrocyte_physiolo | 0.98171948 |
| 90 | MP0005390_skeleton_phenotype | 0.96892712 |
| 91 | MP0004130_abnormal_muscle_cell | 0.96379788 |
| 92 | MP0005275_abnormal_skin_tensile | 0.95691515 |
| 93 | MP0010630_abnormal_cardiac_muscle | 0.93603333 |
| 94 | MP0002009_preneoplasia | 0.93224033 |
| 95 | MP0004087_abnormal_muscle_fiber | 0.89573661 |
| 96 | MP0005623_abnormal_meninges_morphology | 0.86553995 |
| 97 | MP0003866_abnormal_defecation | 0.85686070 |
| 98 | MP0002060_abnormal_skin_morphology | 0.85432807 |
| 99 | MP0000749_muscle_degeneration | 0.85402159 |
| 100 | MP0009763_increased_sensitivity_to | 0.84894156 |
| 101 | MP0002019_abnormal_tumor_incidence | 0.84857151 |
| 102 | MP0001243_abnormal_dermal_layer | 0.84416540 |
| 103 | MP0008469_abnormal_protein_level | 0.84066999 |
| 104 | MP0003075_altered_response_to | 0.83880570 |
| 105 | MP0003950_abnormal_plasma_membrane | 0.82818405 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.82217776 |
| 107 | MP0001915_intracranial_hemorrhage | 0.80802899 |
| 108 | MP0008057_abnormal_DNA_replication | 0.80407342 |
| 109 | MP0009384_cardiac_valve_regurgitation | 0.80299338 |
| 110 | MP0005310_abnormal_salivary_gland | 0.77159787 |
| 111 | MP0000249_abnormal_blood_vessel | 0.76914279 |
| 112 | MP0001879_abnormal_lymphatic_vessel | 0.76761124 |
| 113 | MP0002128_abnormal_blood_circulation | 0.76727976 |
| 114 | MP0008007_abnormal_cellular_replicative | 0.76163803 |
| 115 | MP0003795_abnormal_bone_structure | 0.75569849 |
| 116 | MP0000015_abnormal_ear_pigmentation | 0.74306786 |
| 117 | MP0001663_abnormal_digestive_system | 0.72971562 |
| 118 | MP0004264_abnormal_extraembryonic_tissu | 0.71186630 |
| 119 | MP0003693_abnormal_embryo_hatching | 0.69986186 |
| 120 | MP0005166_decreased_susceptibility_to | 0.69642907 |
| 121 | MP0005330_cardiomyopathy | 0.69376690 |
| 122 | MP0002925_abnormal_cardiovascular_devel | 0.68866317 |
| 123 | MP0003252_abnormal_bile_duct | 0.68335384 |
| 124 | MP0008004_abnormal_stomach_pH | 0.68122130 |
| 125 | MP0004484_altered_response_of | 0.66710311 |
| 126 | MP0005621_abnormal_cell_physiology | 0.66639482 |
| 127 | MP0009115_abnormal_fat_cell | 0.65963898 |
| 128 | MP0009765_abnormal_xenobiotic_induced | 0.64269700 |
| 129 | MP0005058_abnormal_lysosome_morphology | 0.63625733 |
| 130 | MP0001765_abnormal_ion_homeostasis | 0.62919178 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.62660411 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myositis (HP:0100614) | 3.77370658 |
| 2 | Eczematoid dermatitis (HP:0000976) | 3.71613442 |
| 3 | Recurrent abscess formation (HP:0002722) | 3.56107331 |
| 4 | Aortic aneurysm (HP:0004942) | 3.37894939 |
| 5 | Prolonged bleeding time (HP:0003010) | 3.27075854 |
| 6 | Orchitis (HP:0100796) | 3.20778817 |
| 7 | Recurrent bacterial skin infections (HP:0005406) | 3.10624263 |
| 8 | Panhypogammaglobulinemia (HP:0003139) | 3.09250620 |
| 9 | Increased density of long bones (HP:0006392) | 3.07562653 |
| 10 | Granulocytopenia (HP:0001913) | 3.04796123 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 3.04415490 |
| 12 | Optic neuritis (HP:0100653) | 3.04415490 |
| 13 | Gingival bleeding (HP:0000225) | 3.03895380 |
| 14 | Autoimmune hemolytic anemia (HP:0001890) | 3.02700400 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.98376092 |
| 16 | Epistaxis (HP:0000421) | 2.97698781 |
| 17 | Encephalitis (HP:0002383) | 2.90450412 |
| 18 | Aortic dissection (HP:0002647) | 2.88014094 |
| 19 | Protrusio acetabuli (HP:0003179) | 2.86687397 |
| 20 | Recurrent fungal infections (HP:0002841) | 2.84398630 |
| 21 | Obstructive lung disease (HP:0006536) | 2.82852738 |
| 22 | Chronic obstructive pulmonary disease (HP:0006510) | 2.82852738 |
| 23 | Arterial thrombosis (HP:0004420) | 2.82672658 |
| 24 | Agammaglobulinemia (HP:0004432) | 2.74825505 |
| 25 | Interstitial pulmonary disease (HP:0006530) | 2.64607924 |
| 26 | Urticaria (HP:0001025) | 2.60598209 |
| 27 | Increased connective tissue (HP:0009025) | 2.60390159 |
| 28 | Cerebral aneurysm (HP:0004944) | 2.54909005 |
| 29 | Abnormality of the fingertips (HP:0001211) | 2.53611846 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 2.53070100 |
| 31 | Abnormality of eosinophils (HP:0001879) | 2.50469676 |
| 32 | Hematochezia (HP:0002573) | 2.45799083 |
| 33 | Premature rupture of membranes (HP:0001788) | 2.45511189 |
| 34 | Osteolytic defects of the hand bones (HP:0009699) | 2.45237331 |
| 35 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.45237331 |
| 36 | Abnormality of B cell number (HP:0010975) | 2.44221652 |
| 37 | Recurrent viral infections (HP:0004429) | 2.43738087 |
| 38 | T lymphocytopenia (HP:0005403) | 2.41348470 |
| 39 | Abnormality of T cell number (HP:0011839) | 2.39854598 |
| 40 | Persistence of primary teeth (HP:0006335) | 2.39051363 |
| 41 | Pulmonary embolism (HP:0002204) | 2.36064822 |
| 42 | Spondylolisthesis (HP:0003302) | 2.35340155 |
| 43 | Syringomyelia (HP:0003396) | 2.35253162 |
| 44 | Spinal cord lesions (HP:0100561) | 2.35253162 |
| 45 | Cervical subluxation (HP:0003308) | 2.33453977 |
| 46 | Thrombocytosis (HP:0001894) | 2.31003766 |
| 47 | Absent frontal sinuses (HP:0002688) | 2.30992965 |
| 48 | Spontaneous hematomas (HP:0007420) | 2.30526136 |
| 49 | Colitis (HP:0002583) | 2.29805657 |
| 50 | Mediastinal lymphadenopathy (HP:0100721) | 2.29760890 |
| 51 | Fatigue (HP:0012378) | 2.29582135 |
| 52 | Gangrene (HP:0100758) | 2.28324888 |
| 53 | IgM deficiency (HP:0002850) | 2.26774972 |
| 54 | Abnormal platelet volume (HP:0011876) | 2.25742677 |
| 55 | Dilatation of the ascending aorta (HP:0005111) | 2.23178700 |
| 56 | Type 1 muscle fiber predominance (HP:0003803) | 2.22702187 |
| 57 | Pustule (HP:0200039) | 2.22098505 |
| 58 | B lymphocytopenia (HP:0010976) | 2.21268312 |
| 59 | IgG deficiency (HP:0004315) | 2.20778092 |
| 60 | Increased IgM level (HP:0003496) | 2.20440091 |
| 61 | Abnormality of the prostate (HP:0008775) | 2.20212520 |
| 62 | Peritonitis (HP:0002586) | 2.18719578 |
| 63 | Right ventricular cardiomyopathy (HP:0011663) | 2.18633624 |
| 64 | Autoimmune thrombocytopenia (HP:0001973) | 2.16889330 |
| 65 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.16147770 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.15122375 |
| 67 | Cellulitis (HP:0100658) | 2.15012654 |
| 68 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.13355006 |
| 69 | Anorexia (HP:0002039) | 2.12487226 |
| 70 | Keratoconjunctivitis sicca (HP:0001097) | 2.12150303 |
| 71 | Chronic diarrhea (HP:0002028) | 2.12062548 |
| 72 | Osteomyelitis (HP:0002754) | 2.11861837 |
| 73 | Arterial tortuosity (HP:0005116) | 2.11361523 |
| 74 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.11148803 |
| 75 | Vascular tortuosity (HP:0004948) | 2.11033936 |
| 76 | Increased mean platelet volume (HP:0011877) | 2.08094990 |
| 77 | Hypergammaglobulinemia (HP:0010702) | 2.07920353 |
| 78 | Verrucae (HP:0200043) | 2.07414046 |
| 79 | Papilloma (HP:0012740) | 2.07414046 |
| 80 | Severe combined immunodeficiency (HP:0004430) | 2.07215347 |
| 81 | Myocardial infarction (HP:0001658) | 2.07214256 |
| 82 | Recurrent skin infections (HP:0001581) | 2.07128303 |
| 83 | Abnormality of the nasal mucosa (HP:0000433) | 2.06773152 |
| 84 | Abnormality of T cells (HP:0002843) | 2.06631810 |
| 85 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.06331062 |
| 86 | Recurrent cutaneous fungal infections (HP:0011370) | 2.06331062 |
| 87 | Radial bowing (HP:0002986) | 2.05187790 |
| 88 | Skin ulcer (HP:0200042) | 2.04317585 |
| 89 | Muscle fiber inclusion bodies (HP:0100299) | 2.03614519 |
| 90 | Distal lower limb amyotrophy (HP:0008944) | 2.03169798 |
| 91 | Cheilitis (HP:0100825) | 2.03107528 |
| 92 | Alveolar cell carcinoma (HP:0006519) | 2.01357801 |
| 93 | Periodontitis (HP:0000704) | 2.01316748 |
| 94 | Chronic otitis media (HP:0000389) | 2.01264456 |
| 95 | Papilledema (HP:0001085) | 2.01031406 |
| 96 | Ankle contracture (HP:0006466) | 2.00973621 |
| 97 | Abnormality of the pleura (HP:0002103) | 1.99265509 |
| 98 | Ulnar deviation of the wrist (HP:0003049) | 1.98365263 |
| 99 | Nasal polyposis (HP:0100582) | 1.98340882 |
| 100 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.97962203 |
| 101 | Subaortic stenosis (HP:0001682) | 1.97886907 |
| 102 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.97886907 |
| 103 | Subacute progressive viral hepatitis (HP:0006572) | 1.97665748 |
| 104 | Recurrent bronchitis (HP:0002837) | 1.97301584 |
| 105 | Acute myeloid leukemia (HP:0004808) | 1.95938573 |
| 106 | Leukocytosis (HP:0001974) | 1.95586264 |
| 107 | Increased IgE level (HP:0003212) | 1.94871187 |
| 108 | Aneurysm (HP:0002617) | 1.94357163 |
| 109 | Petechiae (HP:0000967) | 1.93652247 |
| 110 | Hypoplasia of the thymus (HP:0000778) | 1.93538556 |
| 111 | Vasculitis (HP:0002633) | 1.92792152 |
| 112 | Difficulty climbing stairs (HP:0003551) | 1.92386491 |
| 113 | Abnormality of the endocardium (HP:0004306) | 1.92162198 |
| 114 | Stomatitis (HP:0010280) | 1.91508744 |
| 115 | Episodic fever (HP:0001954) | 1.91274556 |
| 116 | Sepsis (HP:0100806) | 1.90888265 |
| 117 | Viral hepatitis (HP:0006562) | 1.90660592 |
| 118 | Amyloidosis (HP:0011034) | 1.90643178 |
| 119 | Keratoconjunctivitis (HP:0001096) | 1.90507384 |
| 120 | Frequent falls (HP:0002359) | 1.90328716 |
| 121 | Eosinophilia (HP:0001880) | 1.89903045 |
| 122 | Ventricular tachycardia (HP:0004756) | 1.89564713 |
| 123 | Scapular winging (HP:0003691) | 1.89194088 |
| 124 | Abnormality of the peritoneum (HP:0002585) | 1.87869865 |
| 125 | Chest pain (HP:0100749) | 1.87354875 |
| 126 | Meningitis (HP:0001287) | 1.86789882 |
| 127 | Hemoptysis (HP:0002105) | 1.86698049 |
| 128 | Abnormality of macrophages (HP:0004311) | 1.86006650 |
| 129 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.85490819 |
| 130 | Thyroiditis (HP:0100646) | 1.84892505 |
| 131 | IgA deficiency (HP:0002720) | 1.84210129 |
| 132 | Acute hepatic failure (HP:0006554) | 1.82553024 |
| 133 | Slow saccadic eye movements (HP:0000514) | 1.82415945 |
| 134 | Glomerulopathy (HP:0100820) | 1.81717593 |
| 135 | Mitral valve prolapse (HP:0001634) | 1.80897385 |
| 136 | Gingivitis (HP:0000230) | 1.80823631 |
| 137 | Skin rash (HP:0000988) | 1.80771335 |
| 138 | Nemaline bodies (HP:0003798) | 1.79420751 |
| 139 | Atrophic scars (HP:0001075) | 1.78509756 |
| 140 | Asymmetric septal hypertrophy (HP:0001670) | 1.77604686 |
| 141 | Joint swelling (HP:0001386) | 1.77278868 |
| 142 | Vertigo (HP:0002321) | 1.76930881 |
| 143 | Bicuspid aortic valve (HP:0001647) | 1.76105796 |
| 144 | Gastrointestinal infarctions (HP:0005244) | 1.75009970 |
| 145 | Muscle fiber splitting (HP:0003555) | 1.73891405 |
| 146 | Facial diplegia (HP:0001349) | 1.72633471 |
| 147 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.72012919 |
| 148 | Abnormality of T cell physiology (HP:0011840) | 1.70287723 |
| 149 | Prostate neoplasm (HP:0100787) | 1.70111535 |
| 150 | Inflammation of the large intestine (HP:0002037) | 1.69550491 |
| 151 | Vertebral compression fractures (HP:0002953) | 1.69077070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.86621598 |
| 2 | MAP4K1 | 3.34294876 |
| 3 | TTN | 3.14827975 |
| 4 | JAK3 | 2.43328165 |
| 5 | STK10 | 2.43059302 |
| 6 | PKN2 | 2.42745513 |
| 7 | TRIB3 | 2.32990962 |
| 8 | EEF2K | 2.22918423 |
| 9 | TXK | 2.21127924 |
| 10 | MAP3K14 | 1.97418331 |
| 11 | TYK2 | 1.95754410 |
| 12 | TBK1 | 1.92354047 |
| 13 | TRPM7 | 1.87329845 |
| 14 | DMPK | 1.86193198 |
| 15 | ZAP70 | 1.78740227 |
| 16 | MAP2K3 | 1.75478509 |
| 17 | BMPR2 | 1.72062060 |
| 18 | MAP3K13 | 1.67278594 |
| 19 | ITK | 1.64396836 |
| 20 | KIT | 1.62337277 |
| 21 | TGFBR2 | 1.57543644 |
| 22 | RPS6KA4 | 1.55449812 |
| 23 | PRPF4B | 1.55314769 |
| 24 | LRRK2 | 1.54041797 |
| 25 | JAK1 | 1.53363952 |
| 26 | FGFR4 | 1.50090132 |
| 27 | IKBKE | 1.48613764 |
| 28 | EPHB1 | 1.45987173 |
| 29 | TAOK1 | 1.44246983 |
| 30 | MAP3K3 | 1.43398072 |
| 31 | TEC | 1.42068762 |
| 32 | STK24 | 1.41281810 |
| 33 | LATS1 | 1.41035516 |
| 34 | FGFR3 | 1.37416079 |
| 35 | NEK9 | 1.35496053 |
| 36 | TNK2 | 1.27155988 |
| 37 | IKBKB | 1.26230371 |
| 38 | CSK | 1.25284841 |
| 39 | EPHA3 | 1.23342401 |
| 40 | TAOK3 | 1.21963270 |
| 41 | HCK | 1.19021307 |
| 42 | MOS | 1.18208194 |
| 43 | BTK | 1.17700135 |
| 44 | ERN1 | 1.13148444 |
| 45 | NLK | 1.12090121 |
| 46 | PAK4 | 1.11241491 |
| 47 | CHUK | 1.09767673 |
| 48 | FRK | 1.09344978 |
| 49 | MAP3K1 | 1.07434817 |
| 50 | STK3 | 1.06864005 |
| 51 | IRAK1 | 1.06428691 |
| 52 | NUAK1 | 1.06176453 |
| 53 | EPHA2 | 1.05673010 |
| 54 | FGR | 1.04099571 |
| 55 | MAP3K10 | 1.03203528 |
| 56 | MATK | 1.03166827 |
| 57 | TGFBR1 | 1.02071648 |
| 58 | PIM1 | 1.01280521 |
| 59 | FLT3 | 1.00993182 |
| 60 | PIM2 | 1.00887329 |
| 61 | BLK | 0.95576137 |
| 62 | IRAK4 | 0.94493897 |
| 63 | CSF1R | 0.92703878 |
| 64 | PTK6 | 0.90828795 |
| 65 | LCK | 0.90565776 |
| 66 | MAP3K8 | 0.90295654 |
| 67 | KDR | 0.89902125 |
| 68 | SIK3 | 0.89895440 |
| 69 | OBSCN | 0.88773022 |
| 70 | MARK3 | 0.86172605 |
| 71 | RIPK1 | 0.83732560 |
| 72 | WNK1 | 0.83064210 |
| 73 | PDK1 | 0.82602276 |
| 74 | SCYL2 | 0.82524987 |
| 75 | MAPKAPK3 | 0.81288315 |
| 76 | MAP3K2 | 0.80586039 |
| 77 | MST4 | 0.80265208 |
| 78 | RPS6KB2 | 0.78728075 |
| 79 | MYLK | 0.78400638 |
| 80 | ILK | 0.78341956 |
| 81 | HIPK2 | 0.78076962 |
| 82 | CDK6 | 0.77970968 |
| 83 | CDK12 | 0.75874782 |
| 84 | MARK2 | 0.74583933 |
| 85 | PRKCQ | 0.73679176 |
| 86 | PRKD2 | 0.73598734 |
| 87 | SGK3 | 0.72840698 |
| 88 | RAF1 | 0.72835990 |
| 89 | PIK3CA | 0.72654694 |
| 90 | SGK2 | 0.72616341 |
| 91 | CDC42BPA | 0.71042730 |
| 92 | MAPK7 | 0.70686690 |
| 93 | PDGFRB | 0.69416148 |
| 94 | SYK | 0.69328951 |
| 95 | MAP3K12 | 0.68862261 |
| 96 | PTK2B | 0.68547978 |
| 97 | GRK7 | 0.67622162 |
| 98 | MUSK | 0.66678183 |
| 99 | MAPK12 | 0.66583719 |
| 100 | PRKG2 | 0.66161477 |
| 101 | GRK6 | 0.64669181 |
| 102 | MAP3K5 | 0.63935063 |
| 103 | MELK | 0.62167946 |
| 104 | YES1 | 0.62091768 |
| 105 | IRAK3 | 0.61458910 |
| 106 | CDK9 | 0.61317008 |
| 107 | PAK2 | 0.57296425 |
| 108 | BMX | 0.57238954 |
| 109 | MAPK11 | 0.56641138 |
| 110 | NEK2 | 0.55648710 |
| 111 | PTK2 | 0.55637846 |
| 112 | CDK8 | 0.54736224 |
| 113 | JAK2 | 0.54070520 |
| 114 | CDK4 | 0.53815106 |
| 115 | PIK3CG | 0.53524922 |
| 116 | PDPK1 | 0.53164699 |
| 117 | MAP2K6 | 0.50345687 |
| 118 | NME2 | 0.50035972 |
| 119 | ABL1 | 0.48636610 |
| 120 | CAMK1D | 0.47962158 |
| 121 | MAPKAPK2 | 0.47336357 |
| 122 | ZAK | 0.46216797 |
| 123 | STK4 | 0.46011205 |
| 124 | LYN | 0.45310572 |
| 125 | PDGFRA | 0.45187336 |
| 126 | FYN | 0.44613529 |
| 127 | MAP3K11 | 0.42841922 |
| 128 | STK38 | 0.42630625 |
| 129 | RPS6KL1 | 0.42162754 |
| 130 | RPS6KC1 | 0.42162754 |
| 131 | MAP3K7 | 0.41671959 |
| 132 | MAP3K6 | 0.41569412 |
| 133 | RPS6KA6 | 0.41077621 |
| 134 | TAOK2 | 0.41072676 |
| 135 | FES | 0.39613542 |
| 136 | PRKAA2 | 0.38058001 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.39465468 |
| 2 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.34961927 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.18036618 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.11482742 |
| 5 | Viral myocarditis_Homo sapiens_hsa05416 | 2.11101841 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.98759701 |
| 7 | Measles_Homo sapiens_hsa05162 | 1.93166547 |
| 8 | Shigellosis_Homo sapiens_hsa05131 | 1.82242978 |
| 9 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.77577040 |
| 10 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.74348704 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.68617031 |
| 12 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.68573275 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.68399785 |
| 14 | Malaria_Homo sapiens_hsa05144 | 1.65618867 |
| 15 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65094042 |
| 16 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.62025215 |
| 17 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61899999 |
| 18 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.60559214 |
| 19 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.60491458 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.60034770 |
| 21 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.55113337 |
| 22 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.54269810 |
| 23 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.54200575 |
| 24 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.51667400 |
| 25 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.49444390 |
| 26 | Adherens junction_Homo sapiens_hsa04520 | 1.47925694 |
| 27 | Focal adhesion_Homo sapiens_hsa04510 | 1.47210623 |
| 28 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.46944824 |
| 29 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.45348111 |
| 30 | Allograft rejection_Homo sapiens_hsa05330 | 1.45064575 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.42820314 |
| 32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.42026474 |
| 33 | Hepatitis B_Homo sapiens_hsa05161 | 1.41425267 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36896637 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.35653972 |
| 36 | Platelet activation_Homo sapiens_hsa04611 | 1.34148294 |
| 37 | Legionellosis_Homo sapiens_hsa05134 | 1.33817664 |
| 38 | Salmonella infection_Homo sapiens_hsa05132 | 1.30129953 |
| 39 | Pertussis_Homo sapiens_hsa05133 | 1.28998111 |
| 40 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.28743468 |
| 41 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.27063251 |
| 42 | Tuberculosis_Homo sapiens_hsa05152 | 1.25577854 |
| 43 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.25511971 |
| 44 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.24499527 |
| 45 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.23640982 |
| 46 | Influenza A_Homo sapiens_hsa05164 | 1.23518649 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23378760 |
| 48 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.22697254 |
| 49 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.21606411 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.21019125 |
| 51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.17742658 |
| 52 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.14878105 |
| 53 | Amoebiasis_Homo sapiens_hsa05146 | 1.12003506 |
| 54 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.10503559 |
| 55 | HTLV-I infection_Homo sapiens_hsa05166 | 1.09407804 |
| 56 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.09275421 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.05456975 |
| 58 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05415715 |
| 59 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.99209242 |
| 60 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96495028 |
| 61 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.93629999 |
| 62 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.91256157 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.90942203 |
| 64 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.89006049 |
| 65 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.88794651 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.84849226 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84715496 |
| 68 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81832943 |
| 69 | Colorectal cancer_Homo sapiens_hsa05210 | 0.81765239 |
| 70 | Bladder cancer_Homo sapiens_hsa05219 | 0.77301273 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.73769968 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.73553231 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 0.72426104 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.70592555 |
| 75 | Other glycan degradation_Homo sapiens_hsa00511 | 0.70515889 |
| 76 | Cell cycle_Homo sapiens_hsa04110 | 0.69841126 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.69604530 |
| 78 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68843354 |
| 79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68302461 |
| 80 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.66161356 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.65432643 |
| 82 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61847687 |
| 83 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60655693 |
| 84 | Prostate cancer_Homo sapiens_hsa05215 | 0.60244020 |
| 85 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59933333 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.59629481 |
| 87 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.59526008 |
| 88 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.58245756 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.58171381 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.57445368 |
| 91 | Asthma_Homo sapiens_hsa05310 | 0.56276044 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55415537 |
| 93 | Pathways in cancer_Homo sapiens_hsa05200 | 0.55051370 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.54363172 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.53569387 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53293763 |
| 97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53145859 |
| 98 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.52492230 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51789882 |
| 100 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51363290 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51237242 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51025685 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.49367534 |
| 104 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48870736 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.48810365 |
| 106 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47362732 |
| 107 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46813979 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.45542079 |
| 109 | Lysosome_Homo sapiens_hsa04142 | 0.44797567 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.44675751 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.44168022 |
| 112 | RNA degradation_Homo sapiens_hsa03018 | 0.43529973 |
| 113 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.43411781 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43348168 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42847803 |
| 116 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.41899921 |
| 117 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.40838349 |
| 118 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.40481984 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.36120408 |
| 120 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32280208 |
| 121 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.28614505 |

